NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
49401-088-02 | 49401-088 | HUMAN PRESCRIPTION DRUG | BENLYSTA | belimumab | SOLUTION | SUBCUTANEOUS | 20170720 | N/A | BLA | BLA761043 | GlaxoSmithKline LLC | BELIMUMAB | 200 mg/mL | 1 SYRINGE in 1 CARTON (49401-088-02) / 1 mL in 1 SYRINGE (49401-088-01) |
49401-088-35 | 49401-088 | HUMAN PRESCRIPTION DRUG | BENLYSTA | belimumab | SOLUTION | SUBCUTANEOUS | 20170720 | N/A | BLA | BLA761043 | GlaxoSmithKline LLC | BELIMUMAB | 200 mg/mL | 4 SYRINGE in 1 CARTON (49401-088-35) / 1 mL in 1 SYRINGE (49401-088-01) |
49401-088-47 | 49401-088 | HUMAN PRESCRIPTION DRUG | BENLYSTA | belimumab | SOLUTION | SUBCUTANEOUS | 20170720 | N/A | BLA | BLA761043 | GlaxoSmithKline LLC | BELIMUMAB | 200 mg/mL | 4 SYRINGE in 1 CARTON (49401-088-47) / 1 mL in 1 SYRINGE (49401-088-42) |
49401-088-50 | 49401-088 | HUMAN PRESCRIPTION DRUG | BENLYSTA | belimumab | SOLUTION | SUBCUTANEOUS | 20170720 | N/A | BLA | BLA761043 | GlaxoSmithKline LLC | BELIMUMAB | 200 mg/mL | 1 SYRINGE in 1 CARTON (49401-088-50) / 1 mL in 1 SYRINGE (49401-088-42) |
49401-088-61 | 49401-088 | HUMAN PRESCRIPTION DRUG | BENLYSTA | belimumab | SOLUTION | SUBCUTANEOUS | 20200602 | N/A | BLA | BLA761043 | GlaxoSmithKline LLC | BELIMUMAB | 200 mg/mL | 1 SYRINGE in 1 CARTON (49401-088-61) / 1 mL in 1 SYRINGE |